SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16418408
Source:
http://linkedlifedata.com/resource/pubmed/id/16418408
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0017431
,
umls-concept:C0079488
pubmed:issue
2
pubmed:dateCreated
2006-1-18
pubmed:abstractText
Three point mutations (A2143G, A2142G, and A2142C) have been involved in Helicobacter pylori clarithromycin resistance.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16418408-16418415
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...
,
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin
,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole
,
http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1539-3704
pubmed:author
pubmed-author:BurattiniOsvaldoO
,
pubmed-author:De FrancescoVincenzoV
,
pubmed-author:Di LeoAlfredoA
,
pubmed-author:HassanCesareC
,
pubmed-author:IerardiEnzoE
,
pubmed-author:MarangiStefaniaS
,
pubmed-author:MargiottaMarcellaM
,
pubmed-author:MonnoRosaR
,
pubmed-author:MoriniSergioS
,
pubmed-author:PanellaCarmineC
,
pubmed-author:RussoFrancescoF
,
pubmed-author:StellaFrancescaF
,
pubmed-author:StoppinoVincenzoV
,
pubmed-author:TroianiLauraL
,
pubmed-author:ZulloAngeloA
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
94-100
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16418408-2-Pyridinylmethylsulfinylbenzimidazoles
,
pubmed-meshheading:16418408-Amoxicillin
,
pubmed-meshheading:16418408-Anti-Bacterial Agents
,
pubmed-meshheading:16418408-Benzimidazoles
,
pubmed-meshheading:16418408-Clarithromycin
,
pubmed-meshheading:16418408-Drug Resistance, Bacterial
,
pubmed-meshheading:16418408-Drug Therapy, Combination
,
pubmed-meshheading:16418408-Genotype
,
pubmed-meshheading:16418408-Helicobacter Infections
,
pubmed-meshheading:16418408-Helicobacter pylori
,
pubmed-meshheading:16418408-Humans
,
pubmed-meshheading:16418408-Omeprazole
,
pubmed-meshheading:16418408-Point Mutation
,
pubmed-meshheading:16418408-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.
pubmed:affiliation
Ospedali Riuniti and University of Foggia, Foggia, Italy.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study